Showing: 1 - 2 of 2 RESULTS

Trump, on Sean Hannity’s show, projects optimism about resuming rallies this weekend.

President Trump called into Sean Hannity’s show on Thursday night and, while giving vague answers to questions about his health, suggested a rapid return to the campaign trail that could violate public health guidelines.

Mr. Trump said he wanted to hold a rally in Florida on Saturday — just two days away — and another rally the following night in Pennsylvania. He went on to say he was in “great shape” — even as he paused on a few occasions and seemed to cough or clear his throat — and again presented the monoclonal antibody treatment he received as a miracle cure, even though there is no clinical trial data to evaluate its effectiveness.

He did not give a clear answer when Mr. Hannity asked if he had tested negative for the coronavirus: He first said he wouldn’t get an “actual test” until Friday, then suggested that he had already had a test and that it had found “very little infection or virus, if any,” and then said, “I don’t know if they found any. I didn’t go into it greatly with the doctors.”

Mr. Hannity also pushed the president to denounce the commission organizing this year’s debates for its decision to make next week’s forum virtual — a decision that prompted Mr. Trump to withdraw earlier in the day. At one point, Mr. Hannity suggested that Mr. Trump should organize his own debate.

“Well, I might,” Mr. Trump said, adding that he would want a “fair anchor” — perhaps, he said, Sean Hannity.

Source Article

Abu Dhabi Stem Cells Center and Pluristem Unveil Joint Projects at Malta Conferences Foundation Online Event

 

On Wednesday, September 30, 2020, Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading Israeli regenerative medicine company developing a platform of novel biological products, and the Abu Dhabi Stem Cells Center (ADSCC) unveiled their first joint projects in a presentation at the Malta Conferences Foundation (MCF), a global conference supported by kENUP Foundation, a promoter of research-based innovation with public and societal benefit.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005476/en/

Malta Conferences address shared desire to improve quality of life and political stability in Middle East through scientific collaboration (Graphic: Business Wire)

Pluristem and ADSCC presented new projects, part of the recently signed Memorandum of Understanding aimed at harnessing the power of regenerative medicine.

The first joint project brings together the expertise of Pluristem and ADSCC to advance a potential COVID-19 treatment. The project will involve the first-time administration of Pluristem’s PLX cells via a nebulizer, a drug delivery device that helps a patient inhale medication through a mask or mouthpiece, to COVID-19 patients. The collaboration allows ADSCC to expand their stem cell therapy options using Pluristem’s PLX cells, while enabling Pluristem to leverage ADSCC’s nebulizer administration experience to develop a new treatment delivery model for PLX cells. ADSCC has reported effectively using nebulizers to treat COVID-19 patients with stem cells sourced from the patient’s own blood.

Further discussions for additional projects are underway, including for potential collaboration in chronic Graft Versus Host Disease (cGvHD), a life-threatening immune response of the donor’s stem cells against the host (patient).

The parties presented the joint projects to a distinguished audience at the MCF, including Nobel Laureates, scientists, and diplomats. The foundation’s mission is to address the shared desire to improve quality of life and political stability in the Middle East by identifying opportunities for collaboration to meet the scientific and technological challenges of the region.

“I am delighted for the opportunity to convene this important meeting. The Malta Conferences are the only platform in the world where scientists from 15 Middle East countries, Morocco and Pakistan can get together under the same roof with several Nobel Laureates. They develop collaborations and friendship which overcome the chasms of distrust and intolerance.” said Prof. Zafra Lerman, President of Malta Conferences Foundation.

“Embarking on this journey with Pluristem to overcome one of this generation’s most complex medical challenges marks an exciting new chapter full of possibilities when it comes to knowledge sharing and medical innovation. Our partnership speaks volumes about the power of collaboration between partners across previously divided borders. While we simply do not yet know the long-term impact the novel coronavirus will have on recovered patients, by working together we believe we are able to leverage the best medical technologies and minds in the region to develop solutions to prevent and treat the lingering symptoms and long-term complications that are emerging.” said Dr. Yendry Ventura, General Manager of ADSCC.

“We were very honored to unveil our first joint projects with the ADSCC at the MCF. We see our